Skip to content
Clinical Trials – home

Povidone-Iodine: A Versatile Antiseptic for Various Medical Applications

3 / 4
trials open to patients / all trials
2+
Countries

In short

This article explores the use of Povidone-Iodinated (PVP-I) in clinical trials, focusing on its potential applications in nasal decolonization for MRSA patients and skin preparation for shoulder surgery. These trials aim to evaluate the effectiveness of PVP-I in reducing bacterial colonization and preventing infections in medical settings.

What is Povidone-Iodine?

Povidone-iodine, also known as iodinated povidone or PVP-I, is a widely used antiseptic agent. It is a complex of polyvinylpyrrolidone (povidone) and elemental iodine, which gives it its characteristic brown color. This combination allows for the slow release of iodine, which is the active ingredient responsible for its antimicrobial properties.

Medical Uses

Povidone-iodine is used in various medical applications due to its broad-spectrum antimicrobial activity. Some of its primary uses include:

  • Skin antisepsis: It is commonly used to clean the skin before surgical procedures or injections.
  • Wound care: Povidone-iodine can be applied to minor cuts, scrapes, and burns to prevent infection.
  • Oral hygiene: It is used in mouthwashes to reduce oral bacteria and prevent infections.
  • Nasal decolonization: Recent research is exploring its use in eliminating harmful bacteria from the nasal passages.

Forms and Applications

Povidone-iodine comes in various forms to suit different medical needs:

  • Solution: Used for skin antisepsis and wound cleaning.
  • Gel: Applied to skin or mucous membranes for longer-lasting effects.
  • Mouthwash: For oral hygiene and infection prevention.
  • Foam: Easy-to-apply form for skin cleansing.

Effectiveness

Povidone-iodine has been shown to be effective against a wide range of microorganisms, including bacteria, viruses, and fungi. Its effectiveness is particularly notable in the following areas:

  • MRSA decolonization: Studies are investigating its use in eliminating Methicillin-resistant Staphylococcus aureus (MRSA) from the nasal passages of patients.
  • Surgical site infection prevention: It is commonly used to prepare the skin before surgery to reduce the risk of infection.
  • Oral bacteria reduction: As a mouthwash, it can significantly reduce oral bacterial load.

Safety and Side Effects

While povidone-iodine is generally considered safe for most people, there are some precautions and potential side effects to be aware of:

  • Skin irritation: Some people may experience mild skin irritation or allergic reactions.
  • Thyroid effects: Prolonged use or use on large areas of damaged skin may affect thyroid function.
  • Pregnancy and breastfeeding: Use should be limited during pregnancy and breastfeeding due to potential effects on the fetus or infant.

It's important to follow the instructions provided by your healthcare provider or on the product label, and to discontinue use if you experience any adverse reactions.

Ongoing Research

Current clinical trials are exploring new applications and optimizing the use of povidone-iodine:

  • MRSA decolonization: A study is evaluating the effectiveness of a nasal decolonization kit containing povidone-iodine gel for MRSA patients.
  • Surgical site infection prevention: Research is being conducted on the use of alcoholic povidone-iodine solution in combination with other antiseptics to reduce bacterial colonization before shoulder surgery.

These studies aim to improve infection control strategies and patient outcomes in various medical settings.

Questions people often ask

Conditions where Povidone, Iodinated is being studied

Each condition opens its own overview and trial list

Trials with Povidone, Iodinated

Recruiting trials first

See all 4 →
Quick filters
  • Participants:All ages
  • Participants:Adults
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.

Legal notice · Published by CTIN POLAND sp. z o.o., ul. rtm. Witolda Pileckiego 67/109, 02-781 Warsaw, Poland · KRS 0001111334 · REGON 528919042 · NIP 9512598637

© 2026 Clinical Trials EU – European Clinical Trials Information Network

GDPR compliance, ISO 9001 and ISO 27001 certified (LL-C Certification)

On this site, “treatment” means an investigational medicine being studied in a clinical trial. Its safety and efficacy for the use being studied have not yet been confirmed, some participants may receive a placebo or a comparator medicine, and taking part does not guarantee any health benefit. The decision to take part is made by the doctor at the research site. This site is for information only and does not replace medical advice.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic sites, national regulators and commercial sponsors. On this site, “treatment” and “therapy” mean a medicine being tested in a clinical trial. Its safety and effectiveness in the use being studied are not yet confirmed, some participants may receive a placebo or a comparator, and taking part does not guarantee a health benefit. The doctor at the research site decides who can take part. This site provides information, not medical advice. Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).